A prospective evaluation of a breast cancer prognosis signature in the observational RASTER study

Article English OPEN
Drukker, CA; Bueno-de-Mesquita, JM; Retèl, VP; van Harten, WH; van Tinteren, H; Wesseling, J; Roumen, RMH; Knauer, M; van 't Veer, LJ; Sonke, GS; Rutgers, EJT; van de Vijver, MJ; Linn, SC;
  • Publisher: Blackwell Publishing Ltd
  • Journal: International Journal of Cancer. Journal International du Cancer,volume 133,issue 4,pages929-936 (issn: 0020-7136, eissn: 1097-0215)
  • Publisher copyright policies & self-archiving
  • Related identifiers: pmc: PMC3734625, doi: 10.1002/ijc.28082
  • Subject: Early Detection and Diagnosis | adjuvant systemic treatment | IR-86400 | breast cancer | gene expression profiling | METIS-296793 | prognosis prediction

The 70-gene signature (MammaPrint™) has been developed on retrospective series of breast cancer patients to predict the risk of breast cancer distant metastases. The microarRAy-prognoSTics-in-breast-cancER (RASTER) study was the first study designed to prospectively eva... View more
Share - Bookmark